As a member of the Forum for Innovative Regenerative Medicine (FIRM), CellFiber Inc. has established the "Policy on Transparency in Relationships between Corporate Activities and Medical Institutions" in order to ensure transparency and trust in our relationships with medical institutions—thereby contributing to the advancement of life sciences related to regenerative medicine—and to promote broad understanding that our corporate activities are conducted with a high standard of ethics. We disclose information in accordance with this policy.
Policy on Transparency in Relationships between Corporate Activities and Medical Institutions (PDF)We disclose our expenditures to medical institutions, by fiscal year (April to March, based on our company's fiscal year), as listed below. Viewing this information requires agreement to the Terms of Use.